| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |